Morris Arlene 4
4 · Viridian Therapeutics, Inc.\DE · Filed Jun 10, 2022
Insider Transaction Report
Form 4
Morris Arlene
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-08+12,500→ 12,500 totalExercise: $12.31Exp: 2032-06-08→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]The option vests in full upon the earlier to occur of (i) June 8, 2023 or (ii) the Issuer's 2023 annual meeting of stockholders, subject to Reporting Person's continued service on the Board.